Design, synthesis, and evaluation of a selective chemosensor for leucine-rich repeat kinase 2

David A. Szalewski, Jon R. Beck, Clifford I Stains

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

We describe the design, synthesis, and evaluation of a selective activity probe for leucine-rich repeat kinase 2 (LRRK2), a possible molecular target for the treatment of Parkinson's disease. Our optimal chemosensor design, termed Nictide-S2, incorporates a phosphorylation-sensitive sulfonamido-oxine fluorophore at an engineered cysteine within the substrate sequence. This design allows for the direct, real-time analysis of LRRK2 kinase activity with a detection limit of 2.5 nM. Under optimized conditions, we measured a Z′ factor of 0.7 demonstrating the potential utility of this assay for inhibitor screening. Off-target kinases capable of phosphorylating Nictide-S2 are identified and an optimized inhibitor cocktail for suppressing background signal is provided. The resulting chemosensor could be utilized to identify LRRK2 inhibitors as well as selectively report on LRRK2 activity in the presence of off-target kinases.

Original languageEnglish (US)
Pages (from-to)5648-5651
Number of pages4
JournalBioorganic and Medicinal Chemistry Letters
Volume24
Issue number24
DOIs
StatePublished - Dec 15 2014

Fingerprint

Leucine
Phosphotransferases
Oxyquinoline
Phosphorylation
Fluorophores
Cysteine
Parkinson Disease
Limit of Detection
Assays
Screening
Substrates

Keywords

  • Fluorescence-based biosensor
  • Inhibitor
  • Kinase activity assay
  • LRRK2
  • Parkinson's disease

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmaceutical Science
  • Drug Discovery
  • Clinical Biochemistry
  • Organic Chemistry

Cite this

Design, synthesis, and evaluation of a selective chemosensor for leucine-rich repeat kinase 2. / Szalewski, David A.; Beck, Jon R.; Stains, Clifford I.

In: Bioorganic and Medicinal Chemistry Letters, Vol. 24, No. 24, 15.12.2014, p. 5648-5651.

Research output: Contribution to journalArticle

@article{6d79856af61948e4b56cc6a5f4cfdb1c,
title = "Design, synthesis, and evaluation of a selective chemosensor for leucine-rich repeat kinase 2",
abstract = "We describe the design, synthesis, and evaluation of a selective activity probe for leucine-rich repeat kinase 2 (LRRK2), a possible molecular target for the treatment of Parkinson's disease. Our optimal chemosensor design, termed Nictide-S2, incorporates a phosphorylation-sensitive sulfonamido-oxine fluorophore at an engineered cysteine within the substrate sequence. This design allows for the direct, real-time analysis of LRRK2 kinase activity with a detection limit of 2.5 nM. Under optimized conditions, we measured a Z′ factor of 0.7 demonstrating the potential utility of this assay for inhibitor screening. Off-target kinases capable of phosphorylating Nictide-S2 are identified and an optimized inhibitor cocktail for suppressing background signal is provided. The resulting chemosensor could be utilized to identify LRRK2 inhibitors as well as selectively report on LRRK2 activity in the presence of off-target kinases.",
keywords = "Fluorescence-based biosensor, Inhibitor, Kinase activity assay, LRRK2, Parkinson's disease",
author = "Szalewski, {David A.} and Beck, {Jon R.} and Stains, {Clifford I}",
year = "2014",
month = "12",
day = "15",
doi = "10.1016/j.bmcl.2014.10.079",
language = "English (US)",
volume = "24",
pages = "5648--5651",
journal = "Bioorganic and Medicinal Chemistry Letters",
issn = "0960-894X",
publisher = "Elsevier Limited",
number = "24",

}

TY - JOUR

T1 - Design, synthesis, and evaluation of a selective chemosensor for leucine-rich repeat kinase 2

AU - Szalewski, David A.

AU - Beck, Jon R.

AU - Stains, Clifford I

PY - 2014/12/15

Y1 - 2014/12/15

N2 - We describe the design, synthesis, and evaluation of a selective activity probe for leucine-rich repeat kinase 2 (LRRK2), a possible molecular target for the treatment of Parkinson's disease. Our optimal chemosensor design, termed Nictide-S2, incorporates a phosphorylation-sensitive sulfonamido-oxine fluorophore at an engineered cysteine within the substrate sequence. This design allows for the direct, real-time analysis of LRRK2 kinase activity with a detection limit of 2.5 nM. Under optimized conditions, we measured a Z′ factor of 0.7 demonstrating the potential utility of this assay for inhibitor screening. Off-target kinases capable of phosphorylating Nictide-S2 are identified and an optimized inhibitor cocktail for suppressing background signal is provided. The resulting chemosensor could be utilized to identify LRRK2 inhibitors as well as selectively report on LRRK2 activity in the presence of off-target kinases.

AB - We describe the design, synthesis, and evaluation of a selective activity probe for leucine-rich repeat kinase 2 (LRRK2), a possible molecular target for the treatment of Parkinson's disease. Our optimal chemosensor design, termed Nictide-S2, incorporates a phosphorylation-sensitive sulfonamido-oxine fluorophore at an engineered cysteine within the substrate sequence. This design allows for the direct, real-time analysis of LRRK2 kinase activity with a detection limit of 2.5 nM. Under optimized conditions, we measured a Z′ factor of 0.7 demonstrating the potential utility of this assay for inhibitor screening. Off-target kinases capable of phosphorylating Nictide-S2 are identified and an optimized inhibitor cocktail for suppressing background signal is provided. The resulting chemosensor could be utilized to identify LRRK2 inhibitors as well as selectively report on LRRK2 activity in the presence of off-target kinases.

KW - Fluorescence-based biosensor

KW - Inhibitor

KW - Kinase activity assay

KW - LRRK2

KW - Parkinson's disease

UR - http://www.scopus.com/inward/record.url?scp=84911940526&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84911940526&partnerID=8YFLogxK

U2 - 10.1016/j.bmcl.2014.10.079

DO - 10.1016/j.bmcl.2014.10.079

M3 - Article

C2 - 25467152

AN - SCOPUS:84911940526

VL - 24

SP - 5648

EP - 5651

JO - Bioorganic and Medicinal Chemistry Letters

JF - Bioorganic and Medicinal Chemistry Letters

SN - 0960-894X

IS - 24

ER -